Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study

Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study

<p>Background</p> Plasmodium vivax exacts a significant toll on health worldwide, yet few efforts to date have quantified the extent and temporal trends of its global distribution. Given the challenges associated with the proper diagnosis and treatment of P vivax, national malaria progra...

Bibliografski detalji
Glavni autori:	Battle, K, Lucas, T, Nguyen, M, Howes, R, Nandi, A, Twohig, K, Pfeffer, D, Cameron, E, Rao, P, Casey, D, Gibson, H, Rozier, J, Dalrymple, U, Keddie, S, Collins, E, Harris, J, Guerra, C, Thorn, M, Bisanzio, D, Fullman, N, Huynh, C, Kulikoff, X, Kutz, M, Lopez, A, Mokdad, A, Naghavi, M, Nguyen, G, Shackelford, K, Vos, T, Wang, H, Lim, S, Murray, C, Price, R, Baird, K, Smith, D, Bhatt, S, Weiss, D, Hay, S, Gething, P
Format:	Journal article
Jezik:	English
Izdano:	Elsevier 2019

Slični predmeti

Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000–17: a spatial and temporal modelling study
od: Weiss, D, i dr.
Izdano: (2019)

Growing evidence of Plasmodium vivax across malaria-endemic Africa
od: Twohig, K, i dr.
Izdano: (2019)

Mapping Plasmodium falciparum mortality in Africa between 1990 and 2015
od: Gething, P, i dr.
Izdano: (2016)

malariaAtlas: an R interface to global malariometric data hosted by the Malaria Atlas Project
od: Pfeffer, D, i dr.
Izdano: (2018)

The contribution of non-malarial febrile illness co-infections to plasmodium falciparum case counts in health facilities in sub-Saharan Africa
od: Dalrymple, U, i dr.
Izdano: (2019)

A global map of travel time to cities to assess inequalities in accessibility in 2015
od: Weiss, D, i dr.
Izdano: (2018)

A global map of travel time to cities to assess inequalities in accessibility in 2015
od: Weiss, D, i dr.
Izdano: (2018)

Growing evidence of Plasmodium vivax across malaria-endemic Africa.
od: Katherine A Twohig, i dr.
Izdano: (2019-01-01)

The global public health significance of Plasmodium vivax.
od: Battle, K, i dr.
Izdano: (2012)

malariaAtlas: an R interface to global malariometric data hosted by the Malaria Atlas Project
od: Daniel A. Pfeffer, i dr.
Izdano: (2018-10-01)

Global epidemiology of Plasmodium vivax
od: Howes, R, i dr.
Izdano: (2016)

Global Epidemiology of Plasmodium vivax
od: Howes, R, i dr.
Izdano: (2016)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
od: Baird, J, i dr.
Izdano: (2018)

Defining the relationship between Plasmodium vivax parasite rate and clinical disease.
od: Battle, K, i dr.
Izdano: (2015)

Geographical variation in Plasmodium vivax relapse
od: Battle, K, i dr.
Izdano: (2014)

Geographical variation in Plasmodium vivax relapse.
od: Battle, K, i dr.
Izdano: (2014)

Plasmodium vivax transmission in Africa
od: Howes, R, i dr.
Izdano: (2015)

A long neglected world malaria map: Plasmodium vivax endemicity in 2010.
od: Gething, P, i dr.
Izdano: (2012)

The contribution of non-malarial febrile illness co-infections to Plasmodium falciparum case counts in health facilities in sub-Saharan Africa
od: Ursula Dalrymple, i dr.
Izdano: (2019-06-01)

Mapping malaria seasonality in Madagascar using health facility data
od: Nguyen, M, i dr.
Izdano: (2020)

G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
od: Howes, R, i dr.
Izdano: (2012)

G6PD deficiency: global distribution, genetic variants and primaquine therapy.
od: Howes, R, i dr.
Izdano: (2013)

G6PD Deficiency. Global Distribution, Genetic Variants and Primaquine Therapy
od: Howes, R, i dr.
Izdano: (2013)

Trends in treatment-seeking for fever in children under five years old in 151 countries from 1990 to 2020.
od: Michele Nguyen, i dr.
Izdano: (2023-01-01)

Contemporary epidemiological overview of malaria in Madagascar: operational utility of reported routine case data for malaria control planning
od: Howes, R, i dr.
Izdano: (2016)

Plasmodium falciparum and Plasmodium vivax epidemiology in an era of malaria elimination
od: E. Collins, i dr.
Izdano: (2020-12-01)

Global economic costs due to Plasmodium Vivax malaria treatment and the cost-benefit of radical cure
od: Devine, A, i dr.
Izdano: (2018)

Spatio-temporal mapping of Madagascar’s Malaria Indicator Survey results to assess Plasmodium falciparum endemicity trends between 2011 and 2016
od: Kang, S, i dr.
Izdano: (2018)

Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991-2019
od: Rathmes, G, i dr.
Izdano: (2020)

Mapping malaria seasonality in Madagascar using health facility data
od: Michele Nguyen, i dr.
Izdano: (2020-02-01)

CAN THE SPATIAL DISTRIBUTION OF DUFFY NEGATIVITY EXPLAIN PLASMODIUM VIVAX ABSENCE IN AFRICA?
od: Howes, R, i dr.
Izdano: (2009)

Maps and metrics of insecticide-treated net access, use, and nets-per-capita in Africa from 2000-2020
od: Bertozzi-Villa, A, i dr.
Izdano: (2021)

Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study
od: Devine, A, i dr.
Izdano: (2021)

The international limits and population at risk of Plasmodium vivax transmission in 2009
od: Guerra, C, i dr.
Izdano: (2010)

The burden of Plasmodium vivax malaria
od: Battle, K
Izdano: (2015)

The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
od: Bhatt, S, i dr.
Izdano: (2015)

Coverage and system efficiencies of insecticide-treated nets in Africa from 2000 to 2017.
od: Bhatt, S, i dr.
Izdano: (2015)

The global burden of Plasmodium vivax malaria is obscure and insidious
od: Battle, KE, i dr.
Izdano: (2021)

Global mapping of infectious disease.
od: Hay, S, i dr.
Izdano: (2013)

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
od: Ali, R, i dr.
Izdano: (2016)